Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigallocatechin gallate loaded nanostructured lipid carriers for oral lichen planus
IRCT20230823059238N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of epigallocatechin gallate in oral lichen planus (OLP), sponsored by Tabriz University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20230823059238N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230823059238N1.